What is Wedbush’s Estimate for NHI FY2024 Earnings?

National Health Investors, Inc. (NYSE:NHI) – Research analysts at Wedbush dropped their FY2024 earnings per share estimates for shares of National Health Investors in a research report issued on Wednesday, November 6th. Wedbush analyst R. Anderson now anticipates that the real estate investment trust will post earnings per share of $4.40 for the year, down from their prior estimate of $4.52. The consensus estimate for National Health Investors’ current full-year earnings is $4.42 per share. Wedbush also issued estimates for National Health Investors’ Q4 2024 earnings at $1.10 EPS, Q1 2025 earnings at $1.11 EPS, Q2 2025 earnings at $1.15 EPS, Q3 2025 earnings at $1.16 EPS and Q4 2025 earnings at $1.17 EPS.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The company had revenue of $63.32 million for the quarter, compared to analysts’ expectations of $67.93 million. During the same quarter in the prior year, the firm earned $1.08 EPS. The firm’s revenue was up 1.7% on a year-over-year basis.

Several other research analysts have also commented on NHI. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Truist Financial lifted their price target on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price objective for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, Bank of America assumed coverage on National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $73.29.

National Health Investors Stock Down 1.0 %

NYSE NHI opened at $80.26 on Monday. National Health Investors has a 52 week low of $50.57 and a 52 week high of $86.13. The company has a quick ratio of 10.27, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The business’s fifty day simple moving average is $80.35 and its 200-day simple moving average is $73.74. The firm has a market cap of $3.65 billion, a PE ratio of 27.58, a P/E/G ratio of 5.46 and a beta of 1.05.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be given a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.49%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio is currently 123.71%.

Hedge Funds Weigh In On National Health Investors

Several institutional investors have recently bought and sold shares of the company. Daiwa Securities Group Inc. grew its position in National Health Investors by 7.6% in the 3rd quarter. Daiwa Securities Group Inc. now owns 14,515 shares of the real estate investment trust’s stock valued at $1,220,000 after acquiring an additional 1,027 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of National Health Investors by 17.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock worth $71,651,000 after buying an additional 123,596 shares in the last quarter. Landscape Capital Management L.L.C. acquired a new position in shares of National Health Investors during the third quarter worth about $251,000. Intech Investment Management LLC acquired a new position in shares of National Health Investors during the third quarter worth about $720,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of National Health Investors during the third quarter worth about $282,000. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.